Synopsys Posts Financial Results for First Quarter Fiscal Year 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Synopsys (SNPS) PT Raised to $77 at RBC Capital Following Full Year Guidance Raise
February 16, 2017 7:46 AM ESTRBC Capital Markets analyst Mitch Stevens reiterates Outperform rating and raises price target on Synopsys Inc. (NASDAQ: SPNS) to $77 (from $66), suggesting investments are paying off and margin growth continues, as the company reported results ahead of expectations.
Stevens comments, "Synopsys reported a... More
Synopsys (SNPS) PT Raised to $76 at Needham & Company on Strong F1Q17 Results / F2Q17 Guidance
February 16, 2017 5:59 AM ESTNeedham & Company analyst Richard Valera reiterates Buy rating and raises price target on Synopsys Inc. (NASDAQ: SNPS) to $76 (from $66), as the company reported 2017 fiscal first quarter EPS and revenues well above consensus, while offering strong fiscal second quarter guidance.
Valera notes, "SNPS... More
Synopsys (SNPS) Tops Q1 EPS by 16c; Guides Above Views
February 15, 2017 4:12 PM ESTSynopsys (NASDAQ: SNPS) reported Q1 EPS of $0.94, $0.16 better than the analyst estimate of $0.78. Revenue for the quarter came in at $652.8 million versus the consensus estimate of $637.73 million.
GUIDANCE:
Synopsys sees Q2 2017 EPS of $0.85-$0.88, versus the consensus of $0.77. Synopsys sees Q2... More

